Taken together, from these previous observations, it is plausible to predict that SSTR’s expression in ovarian cancer can be used as a potential target to recognize ovarian cancer by imaging and encountering paclitaxel resistance, which is the only possible therapeutic approach with potential toxicities that can also be minimized by using SST analogs conjugate. Here, SST is linked to ovarian carcinoma.